Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Here, we describe a simple and reproducible protocol of mouse model of infection to evaluate the attenuation of the genetically modified strains of Pseudomonas aeruginosa in comparison to the United States Food and Drug Administration (FDA)-approved Escherichia coli for commercial applications.

Abstract

Microorganisms are genetically versatile and diverse and have become a major source of many commercial products and biopharmaceuticals. Though some of these products are naturally produced by the organisms, other products require genetic engineering of the organism to increase the yields of production. Avirulent strains of Escherichia coli have traditionally been the preferred bacterial species for producing biopharmaceuticals; however, some products are difficult for E. coli to produce. Thus, avirulent strains of other bacterial species could provide useful alternatives for production of some commercial products. Pseudomonas aeruginosa is a common and well-studied Gram-negative bacterium that could provide a suitable alternative to E. coli. However, P. aeruginosa is an opportunistic human pathogen. Here, we detail a procedure that can be used to generate nonpathogenic strains of P. aeruginosa through sequential genomic deletions using the pEX100T-NotI plasmid. The main advantage of this method is to produce a marker-free strain. This method may be used to generate highly attenuated P. aeruginosa strains for the production of commercial products, or to design strains for other specific uses. We also describe a simple and reproducible mouse model of bacterial systemic infection via intraperitoneal injection of validated test strains to test the attenuation of the genetically engineered strain in comparison to the FDA-approved BL21 strain of E. coli.

Introduction

Pseudomonas aeruginosa is an opportunistic bacterial pathogen that can cause life-threatening diseases in humans, especially in the immunocompromised. The pathogenicity of P. aeruginosa is due to the expression of many virulence factors, including proteases and lipopolysaccharide, as well as its ability to form a protective biofilm1. Because of its ability to produce virulence factors and cause disease in humans, using P. aeruginosa to make commercial products presents safety concerns. Nonpathogenic strains of E. coli have traditionally been used to bioengineer medical and commercial products for human use. H....

Protocol

Before beginning animal experiments, the protocol to be used must be approved by the Institutional Animal Care and Use Committee (IACUC). Approval for the protocol described was obtained through the IACUC at Marshall University (Huntington, WV, USA).

1. Plasmid Design

  1. To generate a genetic deletion using the pEX100T-NotI plasmid, clone the regions of DNA flanking the desired deletion sequence and insert into the NotI restriction site of the plasmid. The plasmid insert should contai.......

Representative Results

As shown in Figure 2, the targeted genomic deletion can be confirmed using colony PCR with specific primers that amplify the region of interest. Colonies that carry a genomic deletion will yield a shorter PCR band size in comparison to wild-type colonies. A PCR-screen of 10-12 colonies is usually sufficient to detect at least one colony that carries the targeted deletion. If no deletions are detected after multiple rounds of screens, repeat the procedure begi.......

Discussion

The pEX100T-Not1 plasmid is an efficient mediator of sequential genomic deletions that are marker-free and in-frame. When engineering bacterial strains for attenuated virulence, deletion of entire gene sequences rather than generating point mutations decreases the likelihood of reversion to a virulent phenotype. Additionally, each pathogenicity gene deletion attenuates the pathogen further, reinforcing the stability of the attenuation.

This method can also be used to generate genomic modificat.......

Acknowledgements

This work was supported by the National Institutes of Health (NIH) grants R44GM113545 and P20GM103434.

....

Materials

NameCompanyCatalog NumberComments
0.2 mL tubes with flat capsThermoScientificAB-0620via Fisher Scientific
1 mL SyringeBD22-253-260via Fisher Scientific
1.5 mL disposable polystyrene cuvetteFisher Scientific14955127
1.5 mL Microcentrifuge TubesFisher Scientific05-408-129
2.0 mL Cryogenic VialsCorning430659via Fisher Scientific
27G needleBD14-821-13Bvia Fisher Scientific
50 mL tubesFisher Scientific05-539-13via Fisher Scientific
Accu block Digital Dry BathLabnetNC0205808via Fisher Scientific
Benchtop Centrifuge 5804REppendorf04-987-372via Fisher Scientific
Benchtop MicrocentrifugeSorvall75-003-287via Fisher Scientific
Cabinet IncubatorVWR1540
Carbenicillin disodium saltFisher ScientificBP2648250
Culture Test Tube, PolystyreneFisher Scientific14-956-6Dvia Fisher Scientific
Diposable Inoculation LoopsFisher Scientific22-363-597
Dneasy UltraClean Microbial Kit (50)Qiagen12224-50or preferred method/vendor
E.Z.N.A. Cycle Pure Kit (50)Omega bio-tekD6493-01or preferred method/vendor
EcoRI-HF, restriction endonucleaseNew England BioLabsR3101L
Electroporation CuvettesBulldog BioNC0492929via Fisher Scientific
FastLink II DNA Ligation KitEpicentre TechnologiesLK6201Hvia Fisher Scientific
Gentamycin SulfateFisher ScientificBP918-1
GlycerolFisher ScientificBP229-4
GoTaq G2 Colorless Master MixPromegaM7833via Fisher Scientific
Isothesia IsofluraneHenry Schein Animal Health29405
IVIS Lumina XRMS Series III In Vivo Imaging SystemPerkins and ElmerCLS136340
Kanamycin monosulfateFisher ScientificBP906-5
LE agaroseGenemate3120-500via Fisher Scientific
Luria BrothDifco240230via Fisher Scientific
MicroPulser ElectroporatorBioRad1652100
Noble agar, ultrapureAffymetris/USBAAJ10907A1via Fisher Scientific
NotI-HF, restriction endonucleaseNew England BioLabsR3189
One Shot TOP10 Electrocomp E. coliInvitrogenC404052via Fisher Scientific
Phosphate buffered saline powderSigmaP3813-10PAKSigma-Aldrich
Prism 7GraphPadhttps://www.graphpad.com/scientific-software/prism/
Pseudomonas isolation agarDifco292710via Fisher Scientific
Pseudomonas isolation brothAlpha BiosciencesP16-115Custom made batch
QIAprep Spin Miniprep Kit (250)Qiagen27106or preferred method/vendor
Shaking IncubatorNew Brunswick ScientificInnova 4080shake at 200 rpm
SimpliAmp Thermal CyclerApplied BiosystemsA24811
Skim MilkDifcoDF0032-17-3via Fisher Scientific
Small Plates (100 O.D. x 10 mm)Fisher ScientificFB0875713
SmartSpec Plus SpectrophotometerBio-Rad170-2525or preferred method/vendor
SucroseFisher ScientificS5-500
Toothpicks, roundDiamondAny brand of toothpicks, autoclaved
TOPO TA Cloning Kit, for seqeuncingInvitrogen45-0030
XAF-8 Anesthesia System FiltersPerkins and Elmer118999
XGI 8 Gas Anesthesia SystemCaliper Life Sciences/Xenogen

References

  1. Gellatly, S. L., Hancock, R. E. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathogens and Disease. 67 (3), 159-173 (2013).
  2. Valentine, M. E., et al.

Explore More Articles

Pseudomonas AeruginosaIn frame Gene DeletionVirulence AttenuationMouse Infection ModelReproducibilityCrossover RecombinantColony PCRDouble Crossover RecombinantCarbenicillin SensitivitySucrose ResistanceGene Mutation

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved